哈佛生物科学2024财年第三财季实现净利润-4.80百万美元,同比减少287.10%

市场透视
17 Nov 2024

11月17日,哈佛生物科学(HBIO.US)公布财报,公告显示公司2024财年第三财季净利润为-4.80百万美元,同比减少287.10%;其中营业收入为21.97百万美元,同比减少13.37%,每股基本收益为-0.11美元。从资产负债表来看,哈佛生物科学(HBIO.US)总负债65.92百万美元,其中短期债务4.73百万美元,资产负债比为0.02,流动比率为2.06。机构评级:截至2024年11月...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10